Reviews Concerta


No reviews yet.

Concerta Drug Description
CONCERTA®
(methylphenidate HCl) Extended-Release Tablets

DRUG DEPENDENCE
CONCERTA® should be given cautiously to patients with a
history of drug dependence or alcoholism. Chronic abusive use can lead to
marked tolerance and psychological dependence with varying degrees of abnormal
behavior. Frank psychotic episodes can occur, especially with parenteral abuse.
Careful supervision is required during withdrawal from abusive use since severe
depression may occur. Withdrawal following chronic therapeutic use may unmask
symptoms of the underlying disorder that may require follow-up.

DRUG DESCRIPTION



What are the possible side effects of methylphenidate?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop taking methylphenidate and call your doctor at once if you have any of these serious side effects:

fast, pounding, or uneven heartbeats;
feeling like you might pass out;
fever, sore throat, and headache with a severe blistering, peeling, and red skin rash;
aggression, restlessness, hallucinations,...
Read All Potential Side Effects for Concerta »




CONCERTA® is a central nervous system (CNS) stimulant.
CONCERTA® is available in four tablet strengths. Each extended-release tablet
for once-a-day oral administration contains 18, 27, 36, or 54 mg of
methylphenidate HCl USP and is designed to have a 12-hour duration of effect.
Chemically, methylphenidate HCl is d,l (racemic) methyl
α-phenyl-2-piperidineacetate hydrochloride. Its empirical formula is C14H19NO2•HCl.
Its structural formula is:








Methylphenidate HCl USP is a white, odorless crystalline powder.
Its solutions are acid to litmus. It is freely soluble in water and in
methanol, soluble in alcohol, and slightly soluble in chloroform and in
acetone. Its molecular weight is 269.77.
CONCERTA® also contains the following inert ingredients:
butylated hydroxytoluene, carnauba wax, cellulose acetate, hypromellose,
lactose, phosphoric acid, poloxamer, polyethylene glycol, polyethylene oxides,
povidone, propylene glycol, sodium chloride, stearic acid, succinic acid,
synthetic iron oxides, titanium dioxide, and triacetin.
System Components and Performance
CONCERTA® uses osmotic pressure to deliver methylphenidate
HCl at a controlled rate. The system, which resembles a conventional tablet in
appearance, comprises an osmotically active trilayer core surrounded by a
semipermeable membrane with an immediate-release drug overcoat. The trilayer
core is composed of two drug layers containing the drug and excipients, and a
push layer containing osmotically active components. There is a precision-laser
drilled orifice on the drug-layer end of the tablet. In an aqueous environment,
such as the gastrointestinal tract, the drug overcoat dissolves within one
hour, providing an initial dose of methylphenidate. Water permeates through the
membrane into the tablet core. As the osmotically active polymer excipients
expand, methylphenidate is released through the orifice. The membrane controls
the rate at which water enters the tablet core, which in turn controls drug
delivery. Furthermore, the drug release rate from the system increases with
time over a period of 6 to 7 hours due to the drug concentration gradient
incorporated into the two drug layers of CONCERTA®. The biologically inert
components of the tablet remain intact during gastrointestinal transit and are
eliminated in the stool as a tablet shell along with insoluble core components.
It is possible that CONCERTA® extended-release tablets may be visible on
abdominal x-rays under certain circumstances, especially when digital enhancing
techniques are utilized.Last reviewed on RxList: 11/30/2009




Concerta Drug Description
CONCERTA®
(methylphenidate HCl) Extended-Release Tablets

DRUG DEPENDENCE
CONCERTA® should be given cautiously to patients with a
history of drug dependence or alcoholism. Chronic abusive use can lead to
marked tolerance and psychological dependence with varying degrees of abnormal
behavior. Frank psychotic episodes can occur, especially with parenteral abuse.
Careful supervision is required during withdrawal from abusive use since severe
depression may occur. Withdrawal following chronic therapeutic use may unmask
symptoms of the underlying disorder that may require follow-up.

DRUG DESCRIPTION



What are the possible side effects of methylphenidate?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop taking methylphenidate and call your doctor at once if you have any of these serious side effects:

fast, pounding, or uneven heartbeats;
feeling like you might pass out;
fever, sore throat, and headache with a severe blistering, peeling, and red skin rash;
aggression, restlessness, hallucinations,...
Read All Potential Side Effects for Concerta »




CONCERTA® is a central nervous system (CNS) stimulant.
CONCERTA® is available in four tablet strengths. Each extended-release tablet
for once-a-day oral administration contains 18, 27, 36, or 54 mg of
methylphenidate HCl USP and is designed to have a 12-hour duration of effect.
Chemically, methylphenidate HCl is d,l (racemic) methyl
α-phenyl-2-piperidineacetate hydrochloride. Its empirical formula is C14H19NO2•HCl.
Its structural formula is:








Methylphenidate HCl USP is a white, odorless crystalline powder.
Its solutions are acid to litmus. It is freely soluble in water and in
methanol, soluble in alcohol, and slightly soluble in chloroform and in
acetone. Its molecular weight is 269.77.
CONCERTA® also contains the following inert ingredients:
butylated hydroxytoluene, carnauba wax, cellulose acetate, hypromellose,
lactose, phosphoric acid, poloxamer, polyethylene glycol, polyethylene oxides,
povidone, propylene glycol, sodium chloride, stearic acid, succinic acid,
synthetic iron oxides, titanium dioxide, and triacetin.
System Components and Performance
CONCERTA® uses osmotic pressure to deliver methylphenidate
HCl at a controlled rate. The system, which resembles a conventional tablet in
appearance, comprises an osmotically active trilayer core surrounded by a
semipermeable membrane with an immediate-release drug overcoat. The trilayer
core is composed of two drug layers containing the drug and excipients, and a
push layer containing osmotically active components. There is a precision-laser
drilled orifice on the drug-layer end of the tablet. In an aqueous environment,
such as the gastrointestinal tract, the drug overcoat dissolves within one
hour, providing an initial dose of methylphenidate. Water permeates through the
membrane into the tablet core. As the osmotically active polymer excipients
expand, methylphenidate is released through the orifice. The membrane controls
the rate at which water enters the tablet core, which in turn controls drug
delivery. Furthermore, the drug release rate from the system increases with
time over a period of 6 to 7 hours due to the drug concentration gradient
incorporated into the two drug layers of CONCERTA®. The biologically inert
components of the tablet remain intact during gastrointestinal transit and are
eliminated in the stool as a tablet shell along with insoluble core components.
It is possible that CONCERTA® extended-release tablets may be visible on
abdominal x-rays under certain circumstances, especially when digital enhancing
techniques are utilized.Last reviewed on RxList: 11/30/2009




Concerta Drug Description
CONCERTA®
(methylphenidate HCl) Extended-Release Tablets

DRUG DEPENDENCE
CONCERTA® should be given cautiously to patients with a
history of drug dependence or alcoholism. Chronic abusive use can lead to
marked tolerance and psychological dependence with varying degrees of abnormal
behavior. Frank psychotic episodes can occur, especially with parenteral abuse.
Careful supervision is required during withdrawal from abusive use since severe
depression may occur. Withdrawal following chronic therapeutic use may unmask
symptoms of the underlying disorder that may require follow-up.

DRUG DESCRIPTION



What are the possible side effects of methylphenidate?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop taking methylphenidate and call your doctor at once if you have any of these serious side effects:

fast, pounding, or uneven heartbeats;
feeling like you might pass out;
fever, sore throat, and headache with a severe blistering, peeling, and red skin rash;
aggression, restlessness, hallucinations,...
Read All Potential Side Effects for Concerta »




CONCERTA® is a central nervous system (CNS) stimulant.
CONCERTA® is available in four tablet strengths. Each extended-release tablet
for once-a-day oral administration contains 18, 27, 36, or 54 mg of
methylphenidate HCl USP and is designed to have a 12-hour duration of effect.
Chemically, methylphenidate HCl is d,l (racemic) methyl
α-phenyl-2-piperidineacetate hydrochloride. Its empirical formula is C14H19NO2•HCl.
Its structural formula is:








Methylphenidate HCl USP is a white, odorless crystalline powder.
Its solutions are acid to litmus. It is freely soluble in water and in
methanol, soluble in alcohol, and slightly soluble in chloroform and in
acetone. Its molecular weight is 269.77.
CONCERTA® also contains the following inert ingredients:
butylated hydroxytoluene, carnauba wax, cellulose acetate, hypromellose,
lactose, phosphoric acid, poloxamer, polyethylene glycol, polyethylene oxides,
povidone, propylene glycol, sodium chloride, stearic acid, succinic acid,
synthetic iron oxides, titanium dioxide, and triacetin.
System Components and Performance
CONCERTA® uses osmotic pressure to deliver methylphenidate
HCl at a controlled rate. The system, which resembles a conventional tablet in
appearance, comprises an osmotically active trilayer core surrounded by a
semipermeable membrane with an immediate-release drug overcoat. The trilayer
core is composed of two drug layers containing the drug and excipients, and a
push layer containing osmotically active components. There is a precision-laser
drilled orifice on the drug-layer end of the tablet. In an aqueous environment,
such as the gastrointestinal tract, the drug overcoat dissolves within one
hour, providing an initial dose of methylphenidate. Water permeates through the
membrane into the tablet core. As the osmotically active polymer excipients
expand, methylphenidate is released through the orifice. The membrane controls
the rate at which water enters the tablet core, which in turn controls drug
delivery. Furthermore, the drug release rate from the system increases with
time over a period of 6 to 7 hours due to the drug concentration gradient
incorporated into the two drug layers of CONCERTA®. The biologically inert
components of the tablet remain intact during gastrointestinal transit and are
eliminated in the stool as a tablet shell along with insoluble core components.
It is possible that CONCERTA® extended-release tablets may be visible on
abdominal x-rays under certain circumstances, especially when digital enhancing
techniques are utilized.Last reviewed on RxList: 11/30/2009




Concerta Drug Description
CONCERTA®
(methylphenidate HCl) Extended-Release Tablets

DRUG DEPENDENCE
CONCERTA® should be given cautiously to patients with a
history of drug dependence or alcoholism. Chronic abusive use can lead to
marked tolerance and psychological dependence with varying degrees of abnormal
behavior. Frank psychotic episodes can occur, especially with parenteral abuse.
Careful supervision is required during withdrawal from abusive use since severe
depression may occur. Withdrawal following chronic therapeutic use may unmask
symptoms of the underlying disorder that may require follow-up.

DRUG DESCRIPTION



What are the possible side effects of methylphenidate?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop taking methylphenidate and call your doctor at once if you have any of these serious side effects:

fast, pounding, or uneven heartbeats;
feeling like you might pass out;
fever, sore throat, and headache with a severe blistering, peeling, and red skin rash;
aggression, restlessness, hallucinations,...
Read All Potential Side Effects for Concerta »




CONCERTA® is a central nervous system (CNS) stimulant.
CONCERTA® is available in four tablet strengths. Each extended-release tablet
for once-a-day oral administration contains 18, 27, 36, or 54 mg of
methylphenidate HCl USP and is designed to have a 12-hour duration of effect.
Chemically, methylphenidate HCl is d,l (racemic) methyl
α-phenyl-2-piperidineacetate hydrochloride. Its empirical formula is C14H19NO2•HCl.
Its structural formula is:








Methylphenidate HCl USP is a white, odorless crystalline powder.
Its solutions are acid to litmus. It is freely soluble in water and in
methanol, soluble in alcohol, and slightly soluble in chloroform and in
acetone. Its molecular weight is 269.77.
CONCERTA® also contains the following inert ingredients:
butylated hydroxytoluene, carnauba wax, cellulose acetate, hypromellose,
lactose, phosphoric acid, poloxamer, polyethylene glycol, polyethylene oxides,
povidone, propylene glycol, sodium chloride, stearic acid, succinic acid,
synthetic iron oxides, titanium dioxide, and triacetin.
System Components and Performance
CONCERTA® uses osmotic pressure to deliver methylphenidate
HCl at a controlled rate. The system, which resembles a conventional tablet in
appearance, comprises an osmotically active trilayer core surrounded by a
semipermeable membrane with an immediate-release drug overcoat. The trilayer
core is composed of two drug layers containing the drug and excipients, and a
push layer containing osmotically active components. There is a precision-laser
drilled orifice on the drug-layer end of the tablet. In an aqueous environment,
such as the gastrointestinal tract, the drug overcoat dissolves within one
hour, providing an initial dose of methylphenidate. Water permeates through the
membrane into the tablet core. As the osmotically active polymer excipients
expand, methylphenidate is released through the orifice. The membrane controls
the rate at which water enters the tablet core, which in turn controls drug
delivery. Furthermore, the drug release rate from the system increases with
time over a period of 6 to 7 hours due to the drug concentration gradient
incorporated into the two drug layers of CONCERTA®. The biologically inert
components of the tablet remain intact during gastrointestinal transit and are
eliminated in the stool as a tablet shell along with insoluble core components.
It is possible that CONCERTA® extended-release tablets may be visible on
abdominal x-rays under certain circumstances, especially when digital enhancing
techniques are utilized.Last reviewed on RxList: 11/30/2009




Concerta Drug Description
CONCERTA®
(methylphenidate HCl) Extended-Release Tablets

DRUG DEPENDENCE
CONCERTA® should be given cautiously to patients with a
history of drug dependence or alcoholism. Chronic abusive use can lead to
marked tolerance and psychological dependence with varying degrees of abnormal
behavior. Frank psychotic episodes can occur, especially with parenteral abuse.
Careful supervision is required during withdrawal from abusive use since severe
depression may occur. Withdrawal following chronic therapeutic use may unmask
symptoms of the underlying disorder that may require follow-up.

DRUG DESCRIPTION



What are the possible side effects of methylphenidate?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop taking methylphenidate and call your doctor at once if you have any of these serious side effects:

fast, pounding, or uneven heartbeats;
feeling like you might pass out;
fever, sore throat, and headache with a severe blistering, peeling, and red skin rash;
aggression, restlessness, hallucinations,...
Read All Potential Side Effects for Concerta »




CONCERTA® is a central nervous system (CNS) stimulant.
CONCERTA® is available in four tablet strengths. Each extended-release tablet
for once-a-day oral administration contains 18, 27, 36, or 54 mg of
methylphenidate HCl USP and is designed to have a 12-hour duration of effect.
Chemically, methylphenidate HCl is d,l (racemic) methyl
α-phenyl-2-piperidineacetate hydrochloride. Its empirical formula is C14H19NO2•HCl.
Its structural formula is:








Methylphenidate HCl USP is a white, odorless crystalline powder.
Its solutions are acid to litmus. It is freely soluble in water and in
methanol, soluble in alcohol, and slightly soluble in chloroform and in
acetone. Its molecular weight is 269.77.
CONCERTA® also contains the following inert ingredients:
butylated hydroxytoluene, carnauba wax, cellulose acetate, hypromellose,
lactose, phosphoric acid, poloxamer, polyethylene glycol, polyethylene oxides,
povidone, propylene glycol, sodium chloride, stearic acid, succinic acid,
synthetic iron oxides, titanium dioxide, and triacetin.
System Components and Performance
CONCERTA® uses osmotic pressure to deliver methylphenidate
HCl at a controlled rate. The system, which resembles a conventional tablet in
appearance, comprises an osmotically active trilayer core surrounded by a
semipermeable membrane with an immediate-release drug overcoat. The trilayer
core is composed of two drug layers containing the drug and excipients, and a
push layer containing osmotically active components. There is a precision-laser
drilled orifice on the drug-layer end of the tablet. In an aqueous environment,
such as the gastrointestinal tract, the drug overcoat dissolves within one
hour, providing an initial dose of methylphenidate. Water permeates through the
membrane into the tablet core. As the osmotically active polymer excipients
expand, methylphenidate is released through the orifice. The membrane controls
the rate at which water enters the tablet core, which in turn controls drug
delivery. Furthermore, the drug release rate from the system increases with
time over a period of 6 to 7 hours due to the drug concentration gradient
incorporated into the two drug layers of CONCERTA®. The biologically inert
components of the tablet remain intact during gastrointestinal transit and are
eliminated in the stool as a tablet shell along with insoluble core components.
It is possible that CONCERTA® extended-release tablets may be visible on
abdominal x-rays under certain circumstances, especially when digital enhancing
techniques are utilized.Last reviewed on RxList: 11/30/2009





Other reviews about Concerta on wordpress

Concerta
  by linnic
We have decided to try concerta on my son.  He had been on Metadate with a booster of methylphenadate in the afternoon.  Even with the booster, we were […]


Not Improving
  by linnic
Our summer started out rough, very rough.  I really thought that by now, things would have improved, but they have not.  We are having multiple rages a day, […]


ADD and ADHD Drugs: Ritalin, Adderall, Concerta - Linked to Sudden Death - Seek Alternatives
  by Your Friend
2.5 million out of the 4 million U.S. children diagnosed with attention-deficit disorders are being treated with stimulant drugs. ADHD drugs like Ritalin, Adderall and Concerta supposedly help […]


Concerta - ADHD Medication: Side Effects Including Death
  by Your Friend
The safety of Concerta (methylphenidate), a central nervous system stimulant commonly used to treat Attention Deficit Hyperactivity Disorder (ADHD) in young children, has recently been called into question […]


add adult concerta
  by siazzxgrinama
There are no pretenses with this dating site and it was created by add adult concerta a married couple, two nerds in love, who wanted to help […]


Helped by the Stimulus package
  by yumers
Tim Geithner didn't hand me this little pick-me-up to reinvigorate my state of things, but I was given a prescription for Concerta, a stimulant to combat my persistent […]


First day with Concerta...
  by Carlette
So today will be my first day with Concerta (18mg). I got it prescribed to cope better with my ADHD (symptoms). This morning before i took the first […]


Concerning Concerta
  by yumers
An unfinished paper stares at me in the face, but I can't seem to get it done. All I need to do is read what I've already written […]


uplifting
  by Carlette
Today i am taking concerta since about 6 weeks. Which impact does it have and did it change my life already? Well i have to say that since […]


ADHD - The ugly Concerta or Backlight beauty?
  by gdnf
Flickr Concerta 54 Medication against ADHD and ADD has been so discussed from time to time, so I decided to do some investigation on my own. Is there a […]



Other reviews about Concerta on web:

Learn about ADHD in Children and Adults, treatment options, and how CONCERTA? can help manage ADHD symptoms. CONCERTA® - ADHD Medication to Treat ADHD Symptoms in Children ...


Learn about the prescription medication Concerta (Methylphenidate Extended-Release Tablets), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient ... Concerta (Methylphenidate Extended-Release Tablets) Drug ...


Methylphenidate (MPH; Ritalin, Concerta, Metadate or Methylin) is a psychostimulant drug approved for treatment of attention-deficit hyperactivity disorder, Postural ... Methylphenidate - Wikipedia, the free encyclopedia


Concerta (methylphenidate) is used to treat attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD). Includes Concerta side effects, interactions ... Concerta Information from Drugs.com


Accurate, FDA approved Concerta information for healthcare professionals and patients - brought to you by Drugs.com. Concerta Official FDA information, side effects and uses.


We design and deliver Enterprise Content Management solutions that enable organizations to optimize business processes, increase operational efficiency, reduce costs, and maintain ... Concerta, the leading Enterprise Content Management solutions ...


CONCERTA can help you overcome the daily challenges of Attention Deficit Hyperactivity Disorder (ADHD). Learn about ADHD in adults, and see if CONCERTA is right for you. CONCERTA® For Adult ADHD


Concerta is a once a day stimulant used to treat kids with ADHD or attention deficit hyperactivity disorder. Concerta for Kids with ADHD


Find patient medical information for Concerta Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Concerta Oral : Uses, Side Effects, Interactions, Pictures ...


A Basic overview of the ADHD medication Concerta ... Medications - ADD/ADHD Medications Written by Jeannine Virtue Concerta





Featured Reviews

Reviews Alprazolam

Niravam Drug Description NIRAVAM™ (alprazolam orally disintegrating) Tablets DRUG DESCRIPTION What are the possible side effects of alprazolam (Niravam, Xanax, Xanax XR)? Get emergency medical help if you have any of these...
Read More  |  Review This
Reviews Kemstro

Kemstro Drug Description KEMSTRO™ (baclofen) Orally Disintegrating Tablets DRUG DESCRIPTION KEMSTRO™ (baclofen orally disintegrating tablets) is a muscle relaxant and antispastic. Baclofen USP is a white to off-white, odorless...
Read More  |  Review This
Reviews Triamcinolone Acetonide Cream

Triamcinolone Cream Drug Description Triamcinolone Acetonide Cream USP, 0.1% DRUG DESCRIPTION What are the possible side effects of triamcinolone topical (Cinolar, Kenalog, Triderm)? Get emergency medical help if you have any...
Read More  |  Review This
Reviews Sumavel DosePro

Sumavel DosePro Drug Description Sumavel DosePro (sumatriptan) Injection for Subcutaneous Use DRUG DESCRIPTION Sumatriptan, the active component of Sumavel DosePro, is a selective 5-hydroxy-tryptamine receptor subtype 1 (5-HT1) agonist....
Read More  |  Review This
Reviews Glipizide and Metformin

Metaglip Drug Description METAGLIP™ (glipizide and metformin HCl) Tablets 2.5 mg/250 mg, 2.5 mg/500 mg & 5 mg/500 mg DRUG DESCRIPTION What are the possible side effects of glipizide and metformin (Metaglip)? Get...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....